30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Todd Bazemore

Track

Insider profile

Currently holds positions in KALA BIO Inc and Santhera Pharmaceuticals Holding AG

Performance

Overall performance
2.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 47% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -100%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Operating Officer KALA BIO Inc Nov. 20, 2017 -
Chief Operating Officer Santhera U.S., Member of the Executive Management Board Santhera Pharmaceuticals Holding AG Sept. 6, 2016 -
Executive Vice President and Chief Commercial Officer Dyax Corp April 16, 2014 - Jan. 22, 2016
Todd Bazemore's trades of KALA BIO Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-24 2025-10-22
US KALA BIO Inc (KALA)
S Sale
58,815 -48.3%
70.54
US$71,636 		58,815 -48.3% 70.54 US$71,636
2025-10-22 2025-10-22
US KALA BIO Inc (KALA)
PrS Proposed sale
79,133
381.11
US$1,371,818 		79,133 381.11 US$1,371,818
2025-06-26 2025-06-24
US KALA BIO Inc (KALA)
PlS Planned sale
13,492 +3.9%
464.82
US$4,390,734 		13,492 +3.9% 464.82 US$4,390,734
2025-06-24 2025-06-24
US KALA BIO Inc (KALA)
PrS Proposed sale
4,058
4.01
US$16,273 		4,058 4.01 US$16,273
2025-06-04 2025-06-03
US KALA BIO Inc (KALA)
PlS Planned sale
3,390 -3.7%
3.74
US$12,679 		3,390 -3.7% 3.74 US$12,679
2024-06-27 2024-06-26
US KALA BIO Inc (KALA)
PlS Planned sale
4,653 -5.3%
4.75
US$22,102 		4,653 -5.3% 4.75 US$22,102
2024-06-24 2024-06-24
US KALA BIO Inc (KALA)
PrS Proposed sale
4,356
4.90
US$21,342 		4,356 4.90 US$21,342
2024-06-03 2024-05-31
US KALA BIO Inc (KALA)
PlS Planned sale
2,093 -2.3%
6.09
US$12,746 		2,093 -2.3% 6.09 US$12,746
2023-01-06 2023-01-04
US KALA BIO Inc (KALA)
PlS Planned sale
62 -0.4%
28.54
US$1,769 		62 -0.4% 28.54 US$1,769
2022-10-28 2022-10-26
US KALA BIO Inc (KALA)
PlS Planned sale
214 -9.3%
6.51
US$1,393 		214 -9.3% 6.51 US$1,393
2022-06-29 2022-06-27
US KALA BIO Inc (KALA)
PlS Planned sale
3,092 -2.6%
0.37
US$1,144 		3,092 -2.6% 0.37 US$1,144
2022-01-05 2022-01-04
US KALA BIO Inc (KALA)
PlS Planned sale
3,454 -2.8%
1.30
US$4,490 		3,454 -2.8% 1.30 US$4,490
2021-10-28 2021-10-26
US KALA BIO Inc (KALA)
PlS Planned sale
12,544 -9.3%
1.80
US$22,579 		12,544 -9.3% 1.80 US$22,579
2020-10-28 2020-10-22
US KALA BIO Inc (KALA)
B Purchase
40 +2000.0%
7.60
US$304 		40 +2000.0% 7.60 US$304
2020-10-28 2020-06-05
US KALA BIO Inc (KALA)
B Purchase
2 +inf%
13.39
US$27 		2 +inf% 13.39 US$27
2020-03-17 2020-03-16
US KALA BIO Inc (KALA)
B Purchase
10,000 +inf%
5.75
US$57,500 		10,000 +inf% 5.75 US$57,500